Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Transplantation. 2012 Feb 15;93(3):319–324. doi: 10.1097/TP.0b013e31823f7eea

TABLE 2.

Medication protocol

Pretreatment Rituximab 375 mg/m2 IV
Day1, 4, 7, 11 Plasmapheresis
Methylprednisolone 5 mg/kg (max 100 mg)
Bortezomib 1.3 mg/m2 IV
Day14–16 Plasmapheresis
Day 18 PRA, T-/B-cell subsets
Follow-up after 30 Days PRA, T-/B-cell subsets

PRA, panel reactive antibody.